These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32296111)

  • 1. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide.
    Luo P; Yan H; Chen X; Zhang Y; Zhao Z; Cao J; Zhu Y; Du J; Xu Z; Zhang X; Zeng S; Yang B; Ma S; He Q
    Cell Res; 2020 Sep; 30(9):779-793. PubMed ID: 32296111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition.
    Hasan Alshammari A; Masuo Y; Fujita KI; Shimada K; Iida N; Wakayama T; Kato Y
    Biochem Pharmacol; 2022 Mar; 197():114914. PubMed ID: 35041812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E
    Shichiri H; Yamamoto K; Tokura M; Ishida T; Uda A; Bito T; Nishigori C; Nakagawa T; Hirano T; Yano I; Hirai M
    Biochem Biophys Res Commun; 2017 Apr; 485(2):227-233. PubMed ID: 28237700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
    Zimmerman EI; Gibson AA; Hu S; Vasilyeva A; Orwick SJ; Du G; Mascara GP; Ong SS; Chen T; Vogel P; Inaba H; Maitland ML; Sparreboom A; Baker SD
    Cancer Res; 2016 Jan; 76(1):117-26. PubMed ID: 26677977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.
    Ai L; Xu Z; Yang B; He Q; Luo P
    Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1121-1127. PubMed ID: 31679411
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study.
    Lee YS; Jung YK; Kim JH; Cho SB; Kim DY; Kim MY; Kim HJ; Seo YS; Yoon KT; Hong YM; Lee JH; Lee HW; Yim HJ; Jang BK; Jang ES; Jang JY; Hwang SY
    Eur J Cancer; 2020 Nov; 140():19-27. PubMed ID: 33039810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib.
    Ochi M; Kamoshida T; Ohkawara A; Ohkawara H; Kakinoki N; Hirai S; Yanaka A
    World J Gastroenterol; 2018 Jul; 24(28):3155-3162. PubMed ID: 30065561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ascorbyl-2-phosphate Magnesium on Human Keratinocyte Toxicity and Pathological Changes by Sorafenib.
    Yamamoto K; Shichiri H; Ishida T; Kaku K; Nishioka T; Kume M; Makimoto H; Nakagawa T; Hirano T; Bito T; Nishigori C; Yano I; Hirai M
    Biol Pharm Bull; 2017; 40(9):1530-1536. PubMed ID: 28867735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.
    Chu D; Lacouture ME; Fillos T; Wu S
    Acta Oncol; 2008; 47(2):176-86. PubMed ID: 18210295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.
    Yeh CN; Chung WH; Su SC; Chen YY; Cheng CT; Lin YL; Chang WC; Chung-Yee Hui R; Chiang KC; Chen TW; Jan YY; Chen CW; Chen TJ; Yang CH; Hung SI
    J Invest Dermatol; 2014 Nov; 134(11):2768-2775. PubMed ID: 24802849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Hydroxy-β-methyl Butyrate/L-Arginine/L-Glutamine Supplementation for Preventing Hand-Foot Skin Reaction in Sorafenib for Advanced Hepatocellular Carcinoma.
    Naganuma A; Hoshino T; Ohno N; Ogawa Y; Murakami T; Horiguchi S; Uehara D; Suzuki Y; Hatanaka T; Kudo T; Ishihara H; Sato K; Kakizaki S; Takagi H
    In Vivo; 2019; 33(1):155-161. PubMed ID: 30587616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
    Ren Z; Zhu K; Kang H; Lu M; Qu Z; Lu L; Song T; Zhou W; Wang H; Yang W; Wang X; Yang Y; Shi L; Bai Y; Guo X; Ye SL
    J Clin Oncol; 2015 Mar; 33(8):894-900. PubMed ID: 25667293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma.
    Lee JH; Chung YH; Kim JA; Shim JH; Lee D; Lee HC; Shin ES; Yoon JH; Kim BI; Bae SH; Koh KC; Park NH
    Cancer; 2013 Jan; 119(1):136-42. PubMed ID: 22736425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for sorafenib-induced hand-foot skin reaction using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Yasui K; Hongo F; Yamaguchi K; Moriguchi M; Miki T; Itoh Y
    Am J Health Syst Pharm; 2016 Jan; 73(1):e18-23. PubMed ID: 26683674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma.
    Shinohara N; Nonomura N; Eto M; Kimura G; Minami H; Tokunaga S; Naito S
    Ann Oncol; 2014 Feb; 25(2):472-6. PubMed ID: 24351402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib stimulates human skin type mast cell degranulation and maturation.
    Mizukami Y; Sugawara K; Kira Y; Tsuruta D
    J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands.
    Nonomiya Y; Yokokawa T; Kawakami K; Kobayashi K; Aoyama T; Takiguchi T; Sugisaki T; Suzuki K; Suenaga M; Wakatsuki T; Yamaguchi K; Sugimoto Y; Hama T
    Oncol Res; 2019 May; 27(5):551-556. PubMed ID: 29914591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
    Seo M; Lee MJ; Heo JH; Lee YI; Kim Y; Kim SY; Lee ES; Juhnn YS
    J Biol Chem; 2007 Aug; 282(34):24720-30. PubMed ID: 17548351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of tyrosine kinase inhibitor-induced hand-foot skin reaction: viewpoints from the medical oncologist, dermatologist, and oncology nurse.
    Manchen E; Robert C; Porta C
    J Support Oncol; 2011; 9(1):13-23. PubMed ID: 21465734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.